Skip to main content
SpringerLink
Log in

Amoxicillin/clavulanic-acid/dexamethasone/piperacillin/tazobactam

Lack of efficacy during off-label treatment of COVID-19 pneumonia: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Catteeuw JV, et al. Recombinant human plasma gelsolin (rhu-pGSN) in a patient hospitalized with critical COVID-19 pneumonia. Clinical Infection in Practice 12: Nov 2021. Available from: URL: http://doi.org/10.1016/j.clinpr.2021.100088

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amoxicillin/clavulanic-acid/dexamethasone/piperacillin/tazobactam. Reactions Weekly 1892, 25 (2022). https://doi.org/10.1007/s40278-022-09567-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-09567-0

Search

Navigation